Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

7.16p
   
  • Change Today:
    -0.095p
  • 52 Week High: 19.25p
  • 52 Week Low: 6.75p
  • Currency: UK Pounds
  • Shares Issued: 189.93m
  • Volume: 54,038
  • Market Cap: £13.59m
  • RiskGrade: 348
  • Beta: 0.01

Latest ShareCast News

Renalytix enters new collaboration with NYKHM

By Josh White

Date: Tuesday 03 Jun 2025

(Sharecast News) - Renalytix announced a new collaboration with New York Kidney & Hypertension Medicine (NYKHM) on Tuesday, aimed at expanding access to its FDA-approved kidneyintelX.dkd test across underserved communities in the Greater New York area.

Renalytix Q3 revenues up 20pc

By Iain Gilbert

Date: Thursday 10 Apr 2025

(Sharecast News) - Precision medicine business Renalytix said on Thursday that Q3 trading was in line with expectations, delivering 20% quarter-on-quarter revenue growth as it reached "the key milestone" of processing over 1,000 billable tests within the quarter for the first time.

Renalytix terminates formal sale process

By Josh White

Date: Tuesday 20 Aug 2024

(Sharecast News) - Renalytix, a company specialising in artificial intelligence-enabled diagnostics for kidney disease, announced the termination of its formal sale process on Tuesday.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 7.16p
Change Today -0.095p
% Change -1.31 %
52 Week High 19.25p
52 Week Low 6.75p
Volume 54,038
Shares Issued 189.93m
Market Cap £13.59m
Beta 0.01
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.32% above the market average18.32% above the market average18.32% above the market average18.32% above the market average18.32% above the market average
51.52% above the sector average51.52% above the sector average51.52% above the sector average51.52% above the sector average51.52% above the sector average
Price Trend
58.24% below the market average58.24% below the market average58.24% below the market average58.24% below the market average58.24% below the market average
51.35% below the sector average51.35% below the sector average51.35% below the sector average51.35% below the sector average51.35% below the sector average
Income Not Available
Growth
30.35% below the market average30.35% below the market average30.35% below the market average30.35% below the market average30.35% below the market average
48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average

RENX Dividends

No dividends found

Trades for 04-Jun-2025

Time Volume / Share Price
08:20 54,038 @ 7.38p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page